Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-03, Stock:PFE, The news for the past five days is as follows:
2019-03-27: NEWS1: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS2: Calithera (CALA) Initiates Phase I/II Study of Telaglenastat.NEWS3: After Hours Most Active for Mar 27, 2019 :  TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI.NEWS4: After Hours Most Active for Mar 27, 2019 :  TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI.NEWS5: 6 Stocks With High Dividend Yields.NEWS6: 6 Gene Therapy M&A Targets On The Radar.NEWS7: Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says.
2019-03-28: NEWS1: One Key Strategy to Build Your Ultimate Retirement Portfolio.NEWS2: One Key Strategy to Build Your Ultimate Retirement Portfolio.NEWS3: 3 Big Stock Charts for Thursday: Pfizer, Coty and Pioneer Natural Resources.NEWS4: 3 Big Stock Charts for Thursday: Pfizer, Coty and Pioneer Natural Resources.NEWS5: Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics.NEWS6: Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics.NEWS7: One Key Strategy to Build Your Ultimate Retirement Portfolio.NEWS8: Health Care Sector Update for 03/28/2019: CTST, AMRN, VLRX, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 03/28/2019: CTST, AMRN, VLRX, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics.NEWS11: 3 Big Stock Charts for Thursday: Pfizer, Coty and Pioneer Natural Resources.NEWS12: Calithera (CALA) Initiates Phase I/II Study of Telaglenastat.NEWS13: Calithera (CALA) Initiates Phase I/II Study of Telaglenastat.NEWS14: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS15: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.
2019-03-29: NEWS1: This Dow stock could be a way to play catch-up to the rally.NEWS2: These Are The 5 Worst Dow Jones Stocks Of Q1.NEWS3: Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why.NEWS4: Sarepta (SRPT) Reports Positive Interim Results for DMD Drug.NEWS5: Sarepta (SRPT) Reports Positive Interim Results for DMD Drug.NEWS6: Biotech Stocks Outperform During Inversions: 5 Must Watch.NEWS7: Biotech Stocks Outperform During Inversions: 5 Must Watch.NEWS8: Global Blood Focuses on Developing Lead Candidate Voxelotor.NEWS9: Global Blood Focuses on Developing Lead Candidate Voxelotor.NEWS10: Health Care Sector Update for 03/29/2019: SEEL, VTVT, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 03/29/2019: SEEL, VTVT, AZN, JNJ, PFE, ABT, MRK, AMGN.
2019-04-01: NEWS1: Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics.NEWS2: Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics.NEWS3: Spero Gets Fast Track Designation for SPR994, Shares Improve.NEWS4: Spero Gets Fast Track Designation for SPR994, Shares Improve.NEWS5: Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics.NEWS6: Spero Gets Fast Track Designation for SPR994, Shares Improve.NEWS7: Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts.NEWS8: Saratoga Springs communications firm growing a year after private-equity acquisition.
2019-04-02: NEWS1: Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN.NEWS2: Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN.NEWS3: Gene-Focused Biotechs Pop After Pfizer Partner Scores In Hemophilia A.NEWS4: Why Sangamo Therapeutics Stock Is Soaring Today.NEWS5: Why Sangamo Therapeutics Stock Is Soaring Today.NEWS6: Sangamo Soars Amid Multiple Development Pipeline Updates.NEWS7: Dow Movers: DWDP, AAPL.NEWS8: Dow Movers: DWDP, AAPL.NEWS9: 3 Healthcare Stocks to Trade Now.NEWS10: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS11: Why Sangamo Therapeutics Stock Is Soaring Today.NEWS12: Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia A.NEWS13: Trump delays health care vote until after 2020 election.NEWS14: Sangamo Stock Soars on Positive Hemophilia Treatment Trial.NEWS15: Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Sangamo's stock soars after upbeat trial data for hemophilia treatment.NEWS18: Sangamo&apos;s stock soars after upbeat trial data for hemophilia treatment.NEWS19: Sangamo's stock jumps after upbeat trial data for hemophilia treatment.NEWS20: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy.NEWS21: Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy.

Answer: Decrease